From: NLRP3 inflammasome in cognitive impairment and pharmacological properties of its inhibitors
Antagonist | Specificity | Pharmacological properties | References |
---|---|---|---|
MCC950 | Specifically inhibits NLRP3 activation, but not AIM2, NLRC4, or NLRP1 activation | Independent of K+ efflux, Ca2+ flux, or NLRP3-ASC interaction | |
CY-09 | Specifically inhibits NLRP3 inflammasome activation | Independent of signal 1 (priming step); binds to NLRP3 and inhibits its ATPase activity | |
OLT1177 | Specifically inhibits NLRP3 inflammasome activation, but not AIM2 or NLRC4 inflammasomes | Independent of signal 1 (priming step); binds to NLRP3 and inhibits its ATPase activity | |
Tranilast | Specific inhibitor of NLRP3 inflammasome | Binds to the NACHT domain of NLRP3 to inhibit NLRP3-NLRP3 interaction and subsequent ASC oligomerization | |
Oridonin | Specifically inhibits NLRP3 inflammasome activation, but not AIM2 or NLRC4 inflammasome activation | Binds to cysteine 279 in the NACHT domain to prevent NEK7-NLRP3 interaction |